In addition, we selected 10 clinical biomarkers (CEA, NSE, CA19-9, CA242, CA72-4, AFP, SCC, c-SPA, CA125, and CK19) which were reported to be associated with CRC progress. This evidence concerns the gene KRT19 and colorectal carcinoma.